Popular on TelAve
- EMBER™, the Only Standardized System Linking Workforce Identity to Growth, Appoints Global Brand Visionary Bret Sanford-Chung to Board of Directors - 206
- Iterators Named Preferred Accessibility Testing Vendor by MIT - 202
- Phinge®, Home of Netverse® and Netaverse™ With Verified and Safer AI Announces "Test the Waters" Campaign for Potential Regulation A+ Offering - 200
- OddsTrader Asks: What Are the Chances Your Team Makes the NFL Playoffs? - 199
- FreeTo.Chat Launches Silent Confessions, the Best Confession Site for Anonymous, Ad-Free Truth Sharing - 199
- Assent Joins AWS ISV Accelerate Program - 198
- Sober.Buzz Adds Second Podcast, "Spreading the Good BUZZ" Guest List Grows, Numbers Continue Growing Globally, All While Josh and Heidi Tied the Knot - 197
- Modernizing Pole Data Collection for Next-Gen Network Expansion - 197
- Contracting Resources Group Appears Again on the Inc. List of Fastest-Growing Companies - 196
- Heritage at South Brunswick Announces Two New Building Releases In Townhome Collection - 185
Similar on TelAve
- The Learning Circle Childcare Centre – South Surrey Campus Currently Enrolling for September & Fall
- New Leadership Model – Never Fire Anyone – Released Today
- IOTAP Named to 2025 Inc. 5000 List of America's Fastest-Growing Private Companies
- $5 - $20 Million in Sales for 2026; $25 - $40 Million for 2027 Projected with NASA Agreements; New MOU Signed to Improve Solar Tech in Space
- Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies
- OddsTrader Projects Three Potential Elimination Games in Week 1 of College Football
- The Squires Group Becomes a Workday Partner
- 500% Increase in Revenue for Q2 with Acquisition Plans Including UK Telecom 3D Design/Modeling Company for Global AI Drone & Quantum Computing Leader
- K2 Integrity and Rafidain Bank Launch Strategic Partnership to Strengthen Financial Integrity
- Joint Venture for Expansion Into Asset-Backed Real Estate; $100 Million Initiative via Offering of Shares at Over $4 for Digital Assets: $OFAL
BioLab Holdings, Inc. Launches Its Largest Clinical Trial to Date Evaluating Human Placental Membrane Products
TelAve News/10870861
PHOENIX, July 31, 2025 ~ Phoenix-based medical manufacturer, BioLab Holdings, Inc., has announced the launch of its most comprehensive clinical trial to date. The trial, titled "A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers (BIOCAMP)," aims to evaluate the effectiveness of four human placental membrane (HPM) products in combination with standard of care (SOC) for treating nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).
The trial will enroll 650 participants across up to 30 clinical sites nationwide. According to Dr. Marshall Medley, chief medical officer at BioLab, this study marks a significant milestone in their commitment to advancing wound care through rigorous clinical research. He stated that by evaluating their full suite of amnion-based products in a real-world setting, they hope to provide clinicians with robust data to guide treatment decisions for patients with chronic wounds.
More on TelAve News
Participants will be randomly assigned to receive one of four BioLab products – Tri-Membrane Wrap™ (HPM-1), Membrane Wrap™ (HPM-2), Membrane Wrap-Lite™ (HPM-3), or Membrane Wrap-Hydro™ (HPM-4) – in addition to SOC or SOC alone. Treatments will be applied weekly for up to 12 weeks or until complete wound closure is achieved and confirmed two weeks later. Optional weekly visits will allow for dressing changes in both study arms.
The study is designed to capture real-world clinical outcomes and contribute to the growing body of evidence supporting the use of placental-derived allografts in chronic wound management. For more information on BioLab Holdings, Inc. and its regenerative wound care solutions, interested parties can visit their website at biolabholdings.net.
The trial will enroll 650 participants across up to 30 clinical sites nationwide. According to Dr. Marshall Medley, chief medical officer at BioLab, this study marks a significant milestone in their commitment to advancing wound care through rigorous clinical research. He stated that by evaluating their full suite of amnion-based products in a real-world setting, they hope to provide clinicians with robust data to guide treatment decisions for patients with chronic wounds.
More on TelAve News
- Phinge Previews Its Magnetically Connectable 360° Folding Smartphones-to-Tablets As The Exclusive Gateway to Netverse App-less Rewards-based Platform
- BusinessRate Selects New Jersey Therapy & Life Coaching as Best Couselors
- IRL Investigations Combines Decades of Experience with Modern Digital Expertise
- New Leadership Model – Never Fire Anyone – Released Today
- AureaVault Launches U.S.-Licensed Cryptocurrency Exchange with Enhanced Security Features
Participants will be randomly assigned to receive one of four BioLab products – Tri-Membrane Wrap™ (HPM-1), Membrane Wrap™ (HPM-2), Membrane Wrap-Lite™ (HPM-3), or Membrane Wrap-Hydro™ (HPM-4) – in addition to SOC or SOC alone. Treatments will be applied weekly for up to 12 weeks or until complete wound closure is achieved and confirmed two weeks later. Optional weekly visits will allow for dressing changes in both study arms.
The study is designed to capture real-world clinical outcomes and contribute to the growing body of evidence supporting the use of placental-derived allografts in chronic wound management. For more information on BioLab Holdings, Inc. and its regenerative wound care solutions, interested parties can visit their website at biolabholdings.net.
Filed Under: Business
0 Comments
Latest on TelAve News
- Phinge® Patented Netverse®-Netaverse™ App-less Technology & AI Available Only Through Its Hardware Will Benefit Third Party Businesses & Platforms
- New Book: Cold War Sci-Fi Thriller Arrives Today
- BeeCool Bikes Unveils Next-Generation "Super Frame" with Bee Defender Series
- University of South Pacific and Battery Pollution Technologies Forge Strategic Partnership to tackle Battery End-of-Life Challenges in the Pacific
- Shincheonji Tanzania Church Holds Revelation Bible Exam with Local Pastors and Believers
- Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies
- Phinge's® One-Of-A-Kind Modular Earbuds With Stylish Interchangeable Battery Modules & Dual Charging Case Available Soon for Pre-Sale
- Today's Closeout Reports Strong Enterprise Demand for Wholesale Google Pixel, Expands Wholesale Offering Across Pixel, Apple, and Samsung Portfolios
- Growth Acceleration via Strategic Reverse Split After $10 Million Acquisition for Concerts.com and TicketStub.com; AI Powered Sports/Entertainment Co
- OddsTrader Projects Three Potential Elimination Games in Week 1 of College Football
- Century Fasteners Corp. Exhibiting at the 2025 International Fastener Expo
- Canvas Cloud AI Launches to Transform Cloud Education From Memorization to Mastery
- The Squires Group Becomes a Workday Partner
- From Vernon Hills to Mensa Before Kindergarten
- PermianMuseum.com adds Interstellar Visitor Video Gallery
- SOBREO Elixirs Debut in New York City, Defining a New Era in Inclusive Hospitality
- Allen Field to Showcase Sustainable Paper Handle Applicator at PACK EXPO Las Vegas 2025
- Premier Broadband Wins Fiber-Only BEAD Projects in Four Arkansas Counties
- Laughter, Magic & Mayhem Take Over Las Vegas At Two Hot Locations! Delirious Comedy Club & House of Magic Bring Nonstop Entertainment
- 500% Increase in Revenue for Q2 with Acquisition Plans Including UK Telecom 3D Design/Modeling Company for Global AI Drone & Quantum Computing Leader